NCT00656851View on ClinicalTrials.gov

Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2010

Conditions
HIV InfectionsCardiovascular DiseaseInsulin ResistanceHIV LipodystrophyThe Metabolic Syndrome
Interventions
DRUG

Pioglitazone

30mg/day for 16 weeks

BEHAVIORAL

Exercise Training

Cardiorespiratory and resistance exercise training 3days/wk for 16 weeks

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00656851 - Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome | Biotech Hunter | Biotech Hunter